Routine handling of propofol prevents contamination as effectively as does strict adherence to the manufacturer's recommendations

Canadian Journal of Anesthesia

Volumn 49, Issue 4, 2002, Pages 347-352

  Lorenz, Ingo H ^a   Kolbitsch, Christian ^a   Lass Flörl, Cornelia ^a   Gritznig, Irene ^a   Vollert, Burkard ^a   Lingnau, Werner ^a   Moser, Patrizia L ^a   Benzer, Arnulf ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRESERVATIVE; EDETATE DISODIUM; LIDOCAINE; PROPOFOL; THIOPENTAL;

AMPOULE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISINFECTION; DRUG CONTAMINATION; DRUG MANUFACTURE; DRUG PACKAGING; ENDOSPORE-FORMING RODS AND COCCI; FREQUENCY ANALYSIS; FUNGUS; HUMAN; INFUSION SYSTEM; MAJOR CLINICAL STUDY; MATERIALS HANDLING; MICROBIAL CONTAMINATION; NEUROSURGERY; OPERATING ROOM; PRACTICE GUIDELINE; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; SYRINGE;

EID: 0036099301     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017321     Document Type: Article

References (37)

1. Postoperative infections traced to contamination of an intravenous anesthetic, propofol
2. Postsurgical infections associated with an extrinsically contaminated intravenous anesthetic agent-California, Illinois, Maine, and Michigan
3. Infectious risks associated with the use of propofol
4. Postsurgical Candida albicans infections associated with an extrinsically contaminated intravenous anesthetic agent
5. Severe sepsis after intravenous injection of contaminated propofol (Letter)
6. Microbial growth and endotoxin production in the intravenous anesthetic propofol
7. Staphylococcus aureus bloodstream infections among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by propofol
8. Growth of micro-organisms in solutions of intravenous anaesthetic agents
9. Propofol, but not thiopental, supports the growth of Candida albicans
10. Growth of Staphylococcus aureus in four intravenous anesthetics
11. Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media
12. Endogenous Candida endophthalmitis after intravenous anesthesia with propofol
13. Do intensive care drug infusions support microbial growth?
14. Do infusions of midazolam and propofol pose an infection risk to critically ill patients?
15. Growth of microorganisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopental
16. Antibacterial activity of lidocaine in mixtures with Diprivan
17. The growth of microorganisms in propofol and mixtures of propofol and lidocaine
18. The effect of lidocaine on bacterial growth in propofol
19. Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine
20. 'Diprivan': A change of formulation (Letter)
21. National Nosocomial Infections Surveillance System. Surgical wound infection rates by wound class, operative procedure, and patient risk index
22. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination
23. The nationwide nosocomial infection rate. A new need for vital statistics
24. Bacterial contamination of an anesthetic agent (Editorial)
25. Centers for Disease Control (CDC): Guideline for prevention of intravascular device-related infections. Part 1. Intravascular device-related infections: An overview
26. Drug contamination from opening glass ampules
27. Glass ampules and associated hazards
28. Accidental needle-sticks: Do anesthesiologists practice proper infection control precautions?
29. A microbiological study of the contamination of the syringes used in anaesthesia practice
30. Anaesthetic drugs and bacterial contamination
31. Drawing up propofol (Letter)
32. Bacterial growth in propofol (Letter)
33. Propofol: Can a single ampule be used for multiple patients?
34. In-use contamination of propofol. A clinical study
35. Propofol emulsion and bacterial contamination
36. Contamination of propofol infusions in the intensive care unit: Incidence and clinical significance